The 2018 Genitourinary Cancers Symposium includes exciting research that focuses on effective treatment options for kidney cancer, prostate cancer, and bladder cancer.
After androgen-deprivation therapy for prostate cancer, many couples are surprised by the physical and emotional changes that come into their relationship because of a lack of testosterone.
Survivor and patient advocate Robert Harrison discusses how his metastatic prostate cancer is just one part of his life’s journey.
Research Round Up Podcast: Brain Tumors, Childhood Cancer, Head and Neck Cancer, and Prostate Cancer
Listen to some of the most exciting research news from the 2017 ASCO Annual Meeting in this Research Round Up podcast.
ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.
In this Voices on Cancer blog post, prostate cancer advocate Dennis Golden describes his cancer experience and how he put his professional skills to work advancing his advocacy mission.
In this podcast, Dr. Sumanta Pal gives an overview of research that will be shared at the 2017 Genitourinary Cancers Symposium.
Identifying genetic changes has given us new insights in early detection and treatment of advanced and castration-resistant prostate cancer.
It takes a lot of courage to overcome embarrassment and discomfort, especially when it comes to sexual health. But doing so can lead to happy outcomes.
Active surveillance and watchful waiting are 2 prostate cancer treatments that people often confuse. Pathologist Oleksandr N. Kryvenko, MD, FCAP, explains exactly what they are and who may benefit from them.